Perinatal Outcomes of Pre-viable Preterm Premature Rupture of Membranes

Farhana Mukhtar
{"title":"Perinatal Outcomes of Pre-viable Preterm Premature Rupture of Membranes","authors":"Farhana Mukhtar","doi":"10.24218/JGOB.2018.08","DOIUrl":null,"url":null,"abstract":"Objective: To assess the maternal and neonatal outcomes after expectant management of pre-viable preterm premature rupture of membranes (PPROM). Data Sources: We searched PubMed, Cumulative Index of Nursing and Allied Health Literature (CINAHL), Scopus, and Web of Science databases for publications from 2008 to 2018 and ClinicalTrials.gov. Methods of Study Selection: All studies that reported pregnancy outcomes of pre-viable PPROM were included. Excluded were the review articles, case reports, and studies that exclusively included patients with a particular characteristic (oligohydramnios/prolonged latency), those evaluating the effect of a specific intervention, or the ones providing aggregate data from which information for patients with PPROM <24 weeks could not be delineated. Tabulation, Integration, and Results: Eighteen studies were reviewed that examined the outcomes of 1,372 pre-viable PPROM women following expectant management. Data was extracted in the form of predesigned tables. We used Microsoft Excel to integrate the results of included studies. The overall neonatal survival to discharge was 41.5%. Of these, 48.8% neonates survived without a major morbidity. Respiratory morbidity was the most common morbidity among surviving neonates: 49.5% neonates suffered from respiratory distress syndrome, 30% from bronchopulmonary dysplasia, and 10.7% from pulmonary hypoplasia. Chorioamnionitis was the most frequently observed maternal morbidity, complicating 49.3% pre-viable PPROM. The predictors for favorable outcomes included a later gestational age at PPROM and delivery, absence of oligohydramnios, and iatrogenic PPROM. Of note, 21.6% of pre-viable PPROM women opted for the termination of pregnancy. Conclusion: The neonatal survival rate of pre-viable PPROM after expectant management is 4 of 10 affected neonates, and nearly half of them survive without any major morbidity. Maternal morbidity remains substantial, however, serious maternal complications are rare.","PeriodicalId":104313,"journal":{"name":"Journal of Gynecology and Obstetrics Bulletin","volume":"30 3","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2018-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Gynecology and Obstetrics Bulletin","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.24218/JGOB.2018.08","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Objective: To assess the maternal and neonatal outcomes after expectant management of pre-viable preterm premature rupture of membranes (PPROM). Data Sources: We searched PubMed, Cumulative Index of Nursing and Allied Health Literature (CINAHL), Scopus, and Web of Science databases for publications from 2008 to 2018 and ClinicalTrials.gov. Methods of Study Selection: All studies that reported pregnancy outcomes of pre-viable PPROM were included. Excluded were the review articles, case reports, and studies that exclusively included patients with a particular characteristic (oligohydramnios/prolonged latency), those evaluating the effect of a specific intervention, or the ones providing aggregate data from which information for patients with PPROM <24 weeks could not be delineated. Tabulation, Integration, and Results: Eighteen studies were reviewed that examined the outcomes of 1,372 pre-viable PPROM women following expectant management. Data was extracted in the form of predesigned tables. We used Microsoft Excel to integrate the results of included studies. The overall neonatal survival to discharge was 41.5%. Of these, 48.8% neonates survived without a major morbidity. Respiratory morbidity was the most common morbidity among surviving neonates: 49.5% neonates suffered from respiratory distress syndrome, 30% from bronchopulmonary dysplasia, and 10.7% from pulmonary hypoplasia. Chorioamnionitis was the most frequently observed maternal morbidity, complicating 49.3% pre-viable PPROM. The predictors for favorable outcomes included a later gestational age at PPROM and delivery, absence of oligohydramnios, and iatrogenic PPROM. Of note, 21.6% of pre-viable PPROM women opted for the termination of pregnancy. Conclusion: The neonatal survival rate of pre-viable PPROM after expectant management is 4 of 10 affected neonates, and nearly half of them survive without any major morbidity. Maternal morbidity remains substantial, however, serious maternal complications are rare.
早产儿胎膜早破的围产儿结局
目的:评价活前早产胎膜早破(PPROM)的孕妇和新生儿的预后。数据来源:我们检索了PubMed,护理和相关健康文献累积索引(CINAHL), Scopus和Web of Science数据库,检索了2008年至2018年的出版物和ClinicalTrials.gov。研究选择方法:纳入所有报道活前PPROM妊娠结局的研究。排除综述文章、病例报告和专门纳入具有特定特征(羊水过少/潜伏期延长)的患者的研究,评估特定干预效果的研究,或提供PPROM <24周患者信息的汇总数据的研究。表列、整合和结果:回顾了18项研究,检查了1372名产前PPROM妇女在预期治疗后的结果。数据以预先设计的表格的形式提取。我们使用Microsoft Excel对纳入研究的结果进行整合。新生儿总生存率为41.5%。其中,48.8%的新生儿存活,无重大发病。呼吸系统疾病是存活新生儿中最常见的疾病:49.5%的新生儿患有呼吸窘迫综合征,30%的新生儿患有支气管肺发育不良,10.7%的新生儿患有肺发育不良。绒毛膜羊膜炎是最常见的产妇发病率,并发49.3%的活前PPROM。有利结果的预测因素包括PPROM和分娩时的胎龄较晚,羊水过少,以及医源性PPROM。值得注意的是,21.6%的产前早破妇女选择终止妊娠。结论:产前PPROM经保守治疗后的新生儿存活率为4 / 10,其中近半数存活,无重大并发症。产妇发病率仍然很高,但是,严重的产妇并发症是罕见的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信